Trademark Search in Canada

LYNX

View On IC.GC.CA

REGISTERED

on 13 Dec 2024

Last Applicant/ Owned by

Lyndra Therapeutics, Inc.

65 Grove Street, Suite 301Watertown MA 02472

Serial Number

2196506 filed on 6^th Jun 2022

Registration Number

TMA1275916 registered on 13^th Dec 2024

Registration expiry Date

6^th Jun 2032

Correspondent Address

OSLER, HOSKIN & HARCOURT LLP

Suite 320, World Exchange Plaza100 Queen StreetOttawa,

ONTARIO

K1P1J9

LYNX

Trademark usage description

drug delivery agents in the form of orally administered gastric resident tablets and capsules for the controlled release of the active ingredients of Read More

Classification Information

Class [005]
Drug delivery agents in the form of orally administered gastric resident tablets and capsules for the controlled release of the active ingredients of a wide variety of pharmaceuticals.

Classification kind code

Mark Details

Serial Number

2196506

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 48 on 11^th Jan 2024	Agent Changed
Submitted for opposition 20 on 3^rd Aug 2023	Examiner's First Report
Submitted for opposition 223 on 3^rd Aug 2023	Total Provisional Refusal
Submitted for opposition 22 on 2^th Aug 2023	Search Recorded
Submitted for opposition 256 on 8^th May 2023	Notification of Possible Opposition Sent
Submitted for opposition 257 on 7^th Jul 2022	Designation Notification - Madrid Protocol
Submitted for opposition 1 on 6^th Jul 2022	Created
Submitted for opposition 31 on 6^th Jul 2022	Formalized
Submitted for opposition 30 on 6^th Jun 2022	Filed
Submitted for opposition 228 on 6^th Jun 2022	International Registration

LYNX

Classification Information

Class [005]Drug delivery agents in the form of orally administered gastric resident tablets and capsules for the controlled release of the active ingredients of a wide variety of pharmaceuticals.

Classification kind code

Mark Details

Serial Number

Mark Type

Legal History

Class [005]
Drug delivery agents in the form of orally administered gastric resident tablets and capsules for the controlled release of the active ingredients of a wide variety of pharmaceuticals.